Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
This grant funds NCI-Designated Cancer Centers to support and integrate diverse cancer research, foster collaboration, develop shared resources, and advance cancer prevention, diagnosis, and treatment.
Funder: National Institutes of Health
Due Dates (Anticipated): January 2027 (Full application deadline, projected)
Funding Amounts: Award size varies; typically supports large-scale cancer center infrastructure and research. Duration and total funding depend on center type and scope.
Summary: Supports NCI-Designated Cancer Centers in advancing transdisciplinary cancer research, infrastructure, and community impact.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
Description
This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. The CCSG program funds three types of cancer centers:
- Comprehensive Cancer Centers: Must demonstrate substantial research depth and breadth across basic laboratory, clinical, and prevention/control/population-based research, including significant transdisciplinary activity.
- Clinical Cancer Centers: Focus on basic laboratory, clinical, and/or prevention, cancer control, and population-based research, or a combination.
- Basic Cancer Centers: Emphasize basic laboratory research.
The intent is to leverage institutional cancer research capabilities, integrating meritorious research into a unified, transdisciplinary enterprise. Centers are expected to serve as hubs of discovery for cancer biology, prevention, diagnosis, and therapy; develop and share research resources; collaborate with other NCI-funded programs; and disseminate findings to benefit the broader community.
